share_log

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $124

Benzinga ·  Jan 3 11:24

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $110 to $124.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment